FeesSafety
Pluang+

Authentic Brands completes acquisition of Lee brand IP, plans global expansion.

Company Fundamentals
03 Nov 2026, 13:59 WIB
PRNewsWire
View Source
Bullish
Authentic Brands completes acquisition of Lee brand IP, plans global expansion.

Authentic Brands Group has completed its acquisition of the intellectual property rights to the Lee brand from Kontoor Brands. Lee, a globally recognized denim brand founded in 1889, generates about $1.5 billion in annual retail sales across 73 countries. Authentic plans to expand Lee's reach by leveraging its global platform and partnerships in key markets, including the U.S., Europe, China, and Mexico, to grow the brand through licensing and extend into new product categories like activewear and workwear. This move aims to capitalize on Lee's heritage and consumer loyalty to boost growth worldwide.

Authentic Brands Group's acquisition of Lee provides context for consumer cyclical sector activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Nov 03, 2026 19:01 WIB: Among 134 priced US consumer cyclical stocks, 43 rose and 80 fell today. Notable movers include KMX (CarMax, Inc) at USD 54.75 with a -2.96% change and a typical hold time of 50 days, APTV (Aptiv PLC) at USD 43.00 down 2.78% with a 29% sell and 71% buy order split, and TDUP (ThredUp Inc) at USD 2.14 up 2.39% with a 30-day typical hold time.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App